Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive
aztreonam
ceftazidime-avibactam
metal-beta-lactamases
multidrug-resistant K. pneumoniae
synergism
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2024
2024
Historique:
received:
27
02
2024
accepted:
22
05
2024
medline:
17
6
2024
pubmed:
17
6
2024
entrez:
17
6
2024
Statut:
epublish
Résumé
The difficulties in attaining effective antibiotic therapy arising from the multidrug resistance of Gram-negative bacilli compel the exploration of new possibilities for synergistic interactions among existing antibiotics. An analysis was conducted to assess the efficacy of two antibiotic therapy regimens in the treatment of infections caused by In the group subjected to the treatment regimen involving ceftazidime-avibactam and aztreonam, as compared to alternative antibiotic combinations, a statistically lower mortality rate during the course of treatment and a faster clinical response to the administered therapy were evident. The results obtained may be applicable to routine in vitro assays performed and serve as valuable guidance for the potential utilization of the positive effect of antibiotic therapy through the synergy between ceftazidime-avibactam and aztreonam. The selection of antibiotics employed in the therapy of invasive infections caused by
Sections du résumé
Background
UNASSIGNED
The difficulties in attaining effective antibiotic therapy arising from the multidrug resistance of Gram-negative bacilli compel the exploration of new possibilities for synergistic interactions among existing antibiotics.
Research Design and Methods
UNASSIGNED
An analysis was conducted to assess the efficacy of two antibiotic therapy regimens in the treatment of infections caused by
Results
UNASSIGNED
In the group subjected to the treatment regimen involving ceftazidime-avibactam and aztreonam, as compared to alternative antibiotic combinations, a statistically lower mortality rate during the course of treatment and a faster clinical response to the administered therapy were evident.
Conclusion
UNASSIGNED
The results obtained may be applicable to routine in vitro assays performed and serve as valuable guidance for the potential utilization of the positive effect of antibiotic therapy through the synergy between ceftazidime-avibactam and aztreonam. The selection of antibiotics employed in the therapy of invasive infections caused by
Identifiants
pubmed: 38882656
doi: 10.2147/IDR.S459695
pii: 459695
pmc: PMC11178072
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2307-2313Informations de copyright
© 2024 Szymański et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.